ORXOY (Orexo AB) Price-to-Operating-Cash-Flow : 27.31 (As of Jun. 01, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Orexo AB Price-to-Operating-Cash-Flow?

As of today (2025-06-01), Orexo AB's share price is $1.475. Orexo AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.05. Hence, Orexo AB's Price-to-Operating-Cash-Flow Ratio for today is 27.31.

The historical rank and industry rank for Orexo AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

ORXOY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.63 Med: 9.13 Max: 117.67
Current: 26.02

During the past 13 years, Orexo AB's highest Price-to-Operating-Cash-Flow Ratio was 117.67. The lowest was 4.63. And the median was 9.13.

ORXOY's Price-to-Operating-Cash-Flow is ranked worse than
64.97% of 688 companies
in the Drug Manufacturers industry
Industry Median: 17.14 vs ORXOY: 26.02

Orexo AB's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $0.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 47.90% per year.

During the past 13 years, Orexo AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.90% per year. The lowest was -68.80% per year. And the median was -9.40% per year.

Orexo AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Orexo AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Price-to-Operating-Cash-Flow Chart

Orexo AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

102.46

Orexo AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	26.02

Competitive Comparison of Orexo AB's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orexo AB's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Orexo AB's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Orexo AB Price-to-Operating-Cash-Flow Calculation

Orexo AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.475	/	0.054
	=	27.31

Orexo AB's Share Price of today is $1.475.
Orexo AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Orexo AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Orexo AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ORX:Sweden 0H19:UK

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.